Exact Sciences
EXAS
#1153
Rank
HK$149.28 B
Marketcap
HK$786.70
Share price
-0.07%
Change (1 day)
63.63%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of September 2025 : HK$7.80 Billion

According to Exact Sciences's latest financial reports the company has HK$7.80 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$8.05 B32.69%
2023-12-31HK$6.07 B22.98%
2022-12-31HK$4.93 B-38.54%
2021-12-31HK$8.03 B-43.67%
2020-12-31HK$14.26 B465.88%
2019-12-31HK$2.52 B-71.37%
2018-12-31HK$8.80 B165.3%
2017-12-31HK$3.31 B37.55%
2016-12-31HK$2.41 B1.43%
2015-12-31HK$2.37 B8.45%
2014-12-31HK$2.19 B112.24%
2013-12-31HK$1.03 B23.3%
2012-12-31HK$0.83 B15.58%
2011-12-31HK$0.72 B-2.35%
2010-12-31HK$0.74 B293.64%
2009-12-31HK$0.18 B394.44%
2008-12-31HK$38.15 M-61.13%
2007-12-31HK$98.14 M-40.13%
2006-12-31HK$0.16 B-38.04%
2005-12-31HK$0.26 B-32.3%
2004-12-31HK$0.39 B81.28%
2003-12-31HK$0.21 B-36.96%
2002-12-31HK$0.34 B-22.86%
2001-12-31HK$0.44 B114.7%
2000-12-31HK$0.20 B647.88%
1999-12-31HK$27.6 M-59.63%
1998-12-31HK$68.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Myriad Genetics
MYGN
HK$1.13 B-85.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
HK$2.85 B-63.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
HK$51.63 M-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$81.36 B 941.97%๐Ÿ‡ซ๐Ÿ‡ท France